2007
DOI: 10.1097/mph.0b013e318157fdbd
|View full text |Cite
|
Sign up to set email alerts
|

Warm-reactive Autoantibodies in Pediatric Patients

Abstract: The significance of warm-reactive autoantibodies in pediatric patients has not been a subject of thorough evaluation. This study was undertaken to correlate the clinical and serologic features of these antibodies to identify predictors of clinical significance. Forty-two consecutive patients with serologically detectable warm-reactive autoantibodies were studied. These patients (21 male, 21 female) had a mean age of 9 years (range: 2 mo to 21 y). Primary diagnoses included autoimmune disorders (14), sickle cel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
34
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(35 citation statements)
references
References 24 publications
1
34
0
Order By: Relevance
“…In this situation, alloantibodies are very rare and acute transfusion reactions are uncommon, because the transfused RBCs and the patient’s own RBCs have the same survival in the presence of the autoantibody 38. On the contrary, if the child has previously undergone transfusion, the coexistence of alloantibodies and autoantibodies is common 39. In these patients, the alloantibody is very often shadowed by the panagglutinin, and therefore may produce a delayed haemolytic reaction that would worsen the anaemia 40–42.…”
Section: Treatment Guidelinesmentioning
confidence: 99%
“…In this situation, alloantibodies are very rare and acute transfusion reactions are uncommon, because the transfused RBCs and the patient’s own RBCs have the same survival in the presence of the autoantibody 38. On the contrary, if the child has previously undergone transfusion, the coexistence of alloantibodies and autoantibodies is common 39. In these patients, the alloantibody is very often shadowed by the panagglutinin, and therefore may produce a delayed haemolytic reaction that would worsen the anaemia 40–42.…”
Section: Treatment Guidelinesmentioning
confidence: 99%
“…[2][3][4][5][6] Recent literature contains information from small series, mainly based on laboratory tests, and involving very few centers. [7][8][9][10] The prevalence of AIHA in childhood is still unknown, but likely increases with age, as for most autoimmune disorders. Evans' syndrome (ES) was first described as hemolytic anemia with a positive direct antiglobulin test (DAT) and immune thrombocytopenia occurring simultaneously or in succession, in the absence of any known etiology.…”
Section: Introductionmentioning
confidence: 99%
“…3 Several other laboratory findings can be useful in determining the presence of hemolysis. For example, peripheral tests and complete blood cell counts typically reveal a normochromic, normocytic anemia; polychromasia; and reticulocytosis.…”
Section: Laboratory Findingsmentioning
confidence: 99%
“…2 Although RBC autoantibodies are seen in patients of all ages, a general increase in incidence is observed with age, most dramatically in patients older than 50 years. 3 The RBC autoantibodies are generally classified as either warm RBC autoantibodies, if optimum reactivity with RBCs occurs at 378C, or cold RBC autoantibodies, if optimum reactivity with RBCs occurs at less than 308C.…”
mentioning
confidence: 99%